HANTZ FINANCIAL SERVICES, INC.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1071061
SOUTHFIELD, MI
Position in TEVA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,092,181
-$74,698 QoQ
Shares Held
36,261
-3.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HANTZ FINANCIAL SERVICES, INC. holds $24,766,683 across 26 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
820,071 | $8,208,910 | |
| 2 | ZTS |
Zoetis Inc.
|
48,977 | $5,789,571 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
283,038 | $5,241,863 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,272 | $1,347,250 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
36,261 | $1,092,181 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
41,332 | $572,448 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
3,431 | $451,999 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
17,436 | $417,243 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,092,181 | 36,261 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,166,879 | 37,388 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $439,713 | 21,768 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $102,872 | 6,138 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $6,501 | 423 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||